Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
53.05
+3.75 (7.61%)
May 7, 2026, 4:08 PM HKT

HKG:2315 Statistics

Total Valuation

HKG:2315 has a market cap or net worth of HKD 42.51 billion. The enterprise value is 42.24 billion.

Market Cap42.51B
Enterprise Value 42.24B

Important Dates

The last earnings date was Monday, April 27, 2026.

Earnings Date Apr 27, 2026
Ex-Dividend Date n/a

Share Statistics

HKG:2315 has 446.90 million shares outstanding. The number of shares has increased by 2.01% in one year.

Current Share Class 110.78M
Shares Outstanding 446.90M
Shares Change (YoY) +2.01%
Shares Change (QoQ) +7.03%
Owned by Insiders (%) 14.07%
Owned by Institutions (%) 30.27%
Float 158.02M

Valuation Ratios

The trailing PE ratio is 60.54 and the forward PE ratio is 57.14.

PE Ratio 60.54
Forward PE 57.14
PS Ratio 23.93
PB Ratio 16.36
P/TBV Ratio 16.76
P/FCF Ratio 125.28
P/OCF Ratio 77.73
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 79.81, with an EV/FCF ratio of 124.49.

EV / Earnings 127.94
EV / Sales 23.78
EV / EBITDA 79.81
EV / EBIT 111.21
EV / FCF 124.49

Financial Position

The company has a current ratio of 2.70, with a Debt / Equity ratio of 0.43.

Current Ratio 2.70
Quick Ratio 2.29
Debt / Equity 0.43
Debt / EBITDA 2.13
Debt / FCF 3.33
Interest Coverage 4.78

Financial Efficiency

Return on equity (ROE) is 18.59% and return on invested capital (ROIC) is 19.81%.

Return on Equity (ROE) 18.59%
Return on Assets (ROA) n/a
Return on Invested Capital (ROIC) 19.81%
Return on Capital Employed (ROCE) 11.15%
Weighted Average Cost of Capital (WACC) 5.03%
Revenue Per Employee 1.23M
Profits Per Employee 228,815
Employee Count1,443
Asset Turnover n/a
Inventory Turnover n/a

Taxes

In the past 12 months, HKG:2315 has paid 16.49 million in taxes.

Income Tax 16.49M
Effective Tax Rate 4.76%

Stock Price Statistics

The stock price has increased by +320.37% in the last 52 weeks. The beta is 0.13, so HKG:2315's price volatility has been lower than the market average.

Beta (5Y) 0.13
52-Week Price Change +320.37%
50-Day Moving Average 55.02
200-Day Moving Average 36.58
Relative Strength Index (RSI) 46.55
Average Volume (20 Days) 1,376,625

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2315 had revenue of HKD 1.78 billion and earned 330.18 million in profits. Earnings per share was 0.81.

Revenue1.78B
Gross Profit 1.35B
Operating Income 379.84M
Pretax Income 346.67M
Net Income 330.18M
EBITDA 497.44M
EBIT 379.84M
Earnings Per Share (EPS) 0.81
Full Income Statement

Balance Sheet

The company has 1.40 billion in cash and 1.13 billion in debt, with a net cash position of 269.84 million or 0.60 per share.

Cash & Cash Equivalents 1.40B
Total Debt 1.13B
Net Cash 269.84M
Net Cash Per Share 0.60
Equity (Book Value) 2.60B
Book Value Per Share 5.80
Working Capital 1.31B
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 546.86 million and capital expenditures -207.55 million, giving a free cash flow of 339.31 million.

Operating Cash Flow 546.86M
Capital Expenditures -207.55M
Depreciation & Amortization 118.99M
Net Borrowing -189.83M
Free Cash Flow 339.31M
FCF Per Share 0.76
Full Cash Flow Statement

Margins

Gross margin is 76.18%, with operating and profit margins of 21.39% and 18.59%.

Gross Margin 76.18%
Operating Margin 21.39%
Pretax Margin 19.52%
Profit Margin 18.59%
EBITDA Margin 28.01%
EBIT Margin 21.39%
FCF Margin 19.10%

Dividends & Yields

HKG:2315 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio 5.08%
Buyback Yield -2.01%
Shareholder Yield -2.01%
Earnings Yield 0.78%
FCF Yield 0.80%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2315 has an Altman Z-Score of 6.59 and a Piotroski F-Score of 4.

Altman Z-Score 6.59
Piotroski F-Score 4